-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/main-apps-surv-rept-1-acute-pain.pdf
February 01, 2022 - The decision to update meta-analyses from the original report was based on the number and
sample sizes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/primary-healthcare-spending-draft-tech-brief-appendix-g.xlsx
June 01, 2023 - Connecticut: CT only identifies two specific Place of Service Codes to support their analyses: (a) 2
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
May 01, 2022 - The decision to update meta-analyses from the original report was based on the number and
sample sizes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - Study design Meta-analyses, systematic reviews, RCTs, and nonrandomized controlled
trials for each
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
March 01, 2015 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
April 01, 2013 - review the relevant scientific
literature on topics assigned to them by AHRQ and conduct additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
May 01, 2015 - also are requested by health service researchers to
include family structure information in their analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - the manufacturer, the NDA
addresses questions raised in the FDA's letter and provides additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
January 01, 2010 - Subcutaneous
immunotherapy and pharmacotherapy in seasonal allergic rhinitis:
a comparison based on meta-analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Fidaxomicin shows early superiority over
vancomycin on intention-to-treat analyses of
pivotal randomized
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - perplexing that the authors don’t appear to
support a treat-to-target threshold, yet cite data from analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-clinician-level-strategies-appendixes-draft-tech-brief.pdf
February 01, 2023 - blood pressure self-management in
urban populations with digital barriers: systematic review and meta-analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - to the manufacturer, the
NDA addresses questions raised in the FDA letter and provides additional analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - Fidaxomicin shows early superiority over
vancomycin on intention-to-treat analyses of
pivotal randomized
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
May 23, 2005 - Practice guidelines[mh]
“Practice parameter”
Standard*[ti]
Standards[sh]
“White paper”
Meta-analyses